Peptide Hormones Abuse in Sport: State of the Art in the Detection of Growth Hormone and Erythropoietin

References

• Council of Europe. Report from the 8th meeting of the following-up group belonging to the Anti-doping convention. 1997, Document T-DO (97) 22rÇv
   Google Scholar
• Cowart V. S. Human growth hormone, the latest ergogenic aid?. Physician Sports Medicine 1988; 16: 175–185
   PubMed Web of Science ®Google Scholar
• Macintyre J. G. Growth Hormone and the Athletes. Sports Med 1987; 4: 129–142
   PubMed Web of Science ®Google Scholar
• Christ D. M., Peake G. T., Egan P A, Waters D. L. Body composition response to exogenous GH during training of highly conditioned adults. J. Appl Physiol 1988; 67: 54–61
   Google Scholar
• Christiansen J. S., Jorgensen J. O., Pedersen S. A., Moller J., Jorgensen J, Skakkboek N. E. Effects of growth hormone on body composition in adults. Hormone Res. 1990; 33(suppl 4)61–64
   Google Scholar
• Cuneo R. C., Solomon F., Wiles M, Snksen P. H. Skeletal muscle performance in adults with growth hormone deficiency. Hormone Res. 1990; 33(suppl. 4)55–60
   PubMed Web of Science ®Google Scholar
• Duchaine D. Human Growth Hormone. Underground Steroid Handbook II. HLR Technical Books, California 1989; 74–76
   Google Scholar
• Rogol A. D. Growth Hormone: Physiology, therapeutic use and potential for abuse. Exerc. Sport Sci. Rev 1989; 17: 353–377
   Google Scholar
• Darendelier F., Hindmarsh P. C., Brook C. G.D. Non-conventional use of growth hormone: European experience. Hormone Res. 1990; 33: 128–136
   Google Scholar
• Baumann G., Abramson E C. Urinary growth hormone in man: evidence for multiple molecular forms. J Clin Endocrinol. Metab. 1983; 56: 305–311
   PubMedGoogle Scholar
• Hattori N., Shimatsu A., Kato Y., et al. Urinary excretion of human growth hormone: daily variation and relationship with albumin and alpha-one-microglobulin in urine. Acta Endocrinol. (Copenhagen) 1989; 121: 533–537
   Google Scholar
• Saugy M., Cardis C H., Caron M. J., Gomez F., Landolt S., Rivier L. (1994) Urinary human growth hormone (U-HGH): Alternative to hGH blood test in doping controls?. Blood samples in doping control. Proceedings of the second international symposium on drugs in sports: Towards the use of blood samples in doping controls?, LillehammerNorway, August, 29–311993, P. Hemmersbach, K L Birkeland. On Demand Publishing, Oslo, 53–64, 1994
   Google Scholar
• Rivier Saugy L. M., Cardis C. Endogenous doping agents detection: State-of-the-art and new strategies as demonstrated by the growth hormone problem. Aspects on Forensic Toxicology, A. V. Kovatsis, H. Tsoukali-Papadopoulou. Erasmos, Thessaloniki 1995; 83–87
   Google Scholar
• Saugy Cardis M. C, Rivier L. Urinary human growth hormone (U-hGH) I. Measurements in non-athlete volunteers after intra-muscular or subcutaneous hGH injections. Recent Advances in Doping Analysis, M. Donike, H. Geyer, A. Gotzmann, U. Mareck-Engelke. Sport und Buch Strauss, Koln 1995; Vol. 2: 213–222
   Google Scholar
• Saugy M., Cardis C., Rivier L., Brisson G, Ayotte C., Hemmersbach Haug P. E., Segura J. Urinary human growth hormone (U-hGH) II. Measurements in competition tests. More the expression of the renal function than the endocrinological status. Recent Advances in Doping Analysis, M Donike, H. Geyer, A. Gotzmann, U. Mareck-Engelke. Sport und Buch Strauss, Koln 1995; Vol 2: 223–234
   Google Scholar
• Saugy M., Cardis C h., Schweizer C., Veuthey J.-L., Rivier L. The detection of human growth hormone doping in urine: Out of competition tests are necessary. Journal of Chromatogr B, Special issue: Doping control. 1996; 687: 201–211
   Google Scholar
• Schweizer C, Cardis C., Cauderay M., Rivier L., Saugy M. T/E ratio variation through puberty in male adolescents. Process of the Cologne (1996) workshop on dope analysis. Recent Advances in Doping Analysis, W. Schaenzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke. Sport und Buch Strauss, Koln 1997; Vol. 4: 159–171
   Google Scholar
• Garreau G, Audran M., Baynes R. D., Flowers C. H., Duvallet Senecal A. L., Brisson G. Erythropoietin abuse in athletes. Nature 1996; 380: 113, #6570
   Google Scholar
• Caro J, Schuster S, Ramirez S. The regulation of erythropoietin gene expression. Erythropoietin molecular, cellular and clinical biology, A J Erslev, J W Adamson, J W Eschbach, C G Winearis. Johns Hopkins Univ. Press, Baltimore 1991; 53–64, Chapter 4
   Google Scholar
• Egrie J, Browne J K. The molecular biology of erythropoietin. Erythropoietin molecular, cellular and clinical biology, A J Erslev, J W Adamson, J W Eschbach, C G Winearis. Johns Hopkins Univ Press, Baltimore 1991; 211–240, Chapter 2
   Google Scholar
• Schuster S J, Wilson J H, Erslev A J, et al. Physiologic regulation and metabolism of erythropoietin. Blood 1987; 70: 316–318
   PubMed Web of Science ®Google Scholar
• Conconi F, Casoni I, Manfredini F, Mayyoni G, Grazzi G, Guglielmini C, Ballarin E, Borsetto C, Buzzoni D, Guerra G, Ricci G, Dapporto M, Rigolin I (1990) Detection of erythropoietin administration in sports.(1994) Blood samples in doping control. Proceedings of the second international symposium on drugs in sports: Towards the use of blood samples in doping controls?, LillehammerNorway, August, 29–311993, P. Hemmersbach, K L Birkeland. On Demand Publishing, Oslo, 133–140
   Google Scholar
• Berglund B, Hemmingsson P. Int J. Sports Med. 1987; 8: 231–233
   Google Scholar
• Schmidt W K, Weiglein K. Int J. Sports Med 1996; 17(suppl1)S23
   Google Scholar
• Spivak J L, Cotes P M. The pharmacology and metabolism of erythropoietin. Wineris. Erythropoietin molecular, cellular and clinical biology Baltimore, A J Erslev, J W Adamson, C G Eschbach. Johns Hopkins Univ. Press. 1991; 162–183, Chapter 10
   Google Scholar
• Cotes P M, Spivak J L. Erythropoietin in health and disease. Erythropoietin molecular, cellular and clinical biology, A J Erslev, J W Adamson, J W Eschbach, C G Winearis. Johns Hopkins Univ. Press, Baltimore 1991; 184–207, Chapter 11
   Google Scholar
• Erslev A J. Erythropoietin. New Eng J. Med. 1991; 324: 1339–1344
   PubMed Web of Science ®Google Scholar
• Berglund B, Ekblom B. Effect of recombinant human erythropoietin treatment on blood pressure and some haematological parameters in healthy men. J. Internal Med. 1991; 229: 125–130
   Google Scholar
• Vauthers J P. Erythropoietine recombinante humaine: de la clinique ‡ la physiopathologie de l'anèmie de l'insuffisance rènale. Revue Mèd. Suisse romande 1990; 110: 951–954
   Google Scholar
• Mandin H (1990) Erythropoietin as possible substance for blood doping. Bellotti P Benzi G Ljungqvist, Official proceedings, 2nd I.A.F. World Symposium on Doping in Sport, International Athletic Foundation, Monte Carlo, June, 5–71989. International Athletic Foundation, Monte Carlo, 13–30
   Google Scholar
• Tanabe M, Teshima S, Hanyu T, Hayashi Y. Rapid and sensitive method for Erythropoietin determination in serum. Clin. Chem. 1992; 38: 1752–1755
   Google Scholar
• Wide L, Bengtsson C. Molecular charge heterogeneity of human serum Erythropoietin. Br. J. Haematol 1990; 76: 121–127
   PubMed Web of Science ®Google Scholar
• Adamson J. W., Vapnek D. Recombinant erythropoietin to improve athletic performance. The New England J. Med. 1991; 324: 698–699
   PubMed Web of Science ®Google Scholar
• Ekblom B., Berglund B. Effect of erythropoietin administration on maximal aerobic power. Scand. J Med. Sci Sports 1991; 1: 88–93
   Google Scholar
• Walder G. I., Hainline B. Blood doping and erythropoietin. Drugs and the Athlete, A. J. Ryan. F.A. Davis, Philadelphia 1989; 172–177
   Google Scholar
• Berglund B. Development of techniques for the detection of blood doping in sport. Sports Med. 1988; 5: 127–135
   Google Scholar
• Berglund B. Blood doping and erythropoietin. The effects of variation in haemoglobin concentration and other related factors on physical performance. Am. J Sports Med. 1996; 24: S40–S42
   Google Scholar
• Wide L. Detection in blood and urine of recombinant erythropoietin administered to healthy men. Med. Sci. Sports Exerc. 1995; 27: 1569–1576
   PubMed Web of Science ®Google Scholar
• Salomonson T., Danielson B. G., Wikstrom B. The pharmacokinetic of recombinant human erythropoietin after intravenous and subcutaneous administration to healthy subjects. Br J Clin Pharmacol. 1990; 29: 709–713
   Google Scholar
• Garreau G, Brisson G. R., Chenard C., Gagnon M. G., Richalet J. P., Audran M. Discrimination possible entre entraonement en altitude et dopage l'èrythropoiètine. Sci. et Sports 1995; 10: 81–82
   Google Scholar
• Saugy M., Cardis C., Cauderay M., Schweizer C, Robinson N., Rivier L., Mangin P. (submitted) One year experience of haematocrit measurements in professional cycling: preventive approach for an acute doping problem. Proceedings of the 14th Cologne (1998) workshop on dope analysis Recent Advances in Doping Analysis. 1998, W. Schaenzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke. Sport und Buch Strauss, Koln, Vol. 6
   Google Scholar
• Garreau R, Audran M, et al. Nature 1996; 380: 113
   Google Scholar
• Casoni I, Ricci G, Ballarin E. Haematological indices of erythropoietin administration in athletes. Int. J. Sports Med. 1993; 14: 307–311
   Google Scholar
• Bowers L. D., Borts D. J. Evaluation of selected-ion storage ion-trap mass spectrometry for detecting urinary anabolic agents. Clin Chem 1997; 43: 1033–1039
   Google Scholar
• Lau B. P.-Y., Lewis D., Lawrence J. F. Confirmation analysis of clenbuterol in beef liver and minced beef by a combination of immunoaffinity chromatography and liquid chromatography electrospray mass spectrometry or liquid chromatography electrospray tandem mass spectrometry. J Mass Spectrom. 1997; 32: 655–661
   Google Scholar
• Rizea Savu S., Silvestro L., Haag A., Soergel F. A confirmatory HPLC-MSMS method for ten synthetic corticosteroids in bovine urines. J. Mass Spectrom. 1996; 31: 1351–1363
   Google Scholar
• Bowers L. D., Borts D. J. Separation and confirmation of anabolic steroids with quadrupole ion trap tandem mass spectrometry. J Chromatogr. B 1996; 687: 69–78
   PubMed Web of Science ®Google Scholar
• Arcelloni C., Fermo I., Banfi G., Pontiroli A. E., Paroni R. Capillary electrophoresis for protein analysis: separation of human growth hormone and human insulin molecular forms. Anal Biochem 1993; 212: 160–167
   Google Scholar
• Kabouris M., Platen P., Donike M. Detection of human growth hormone in urine of athletes. Recent Advances in Doping Analysis Vol. 3, M. Donike, H. Geyer, A. Gotzmann, U. Mareck-Engelke. Sport und Buch Strauss, Kln 1996; 313–323
   Google Scholar
• Ellis J. D., Hand E. L., Gilbert J. D. Use of LC-MS/MS to cross-validate a radioimmunoassay for the fibrinogen receptor antagonist, Aggrastat (tirofiban hydrochloride) in human plasma. J Pharmaceut. Biochem. Anal. 1997; 15: 561–569
   PubMed Web of Science ®Google Scholar
• Roberts N. B., Green B. N., Morris M. Potential of electrospray mass spectrometry for quantifying glycohaemoglobin. Clin Chem. 1997; 43: 771–778
   PubMedGoogle Scholar
• Boss H. J., Rohde M. F., Rush R. S. Multiple sequential fraction collection of peptides and glycopeptides by high-performance capillary electrophoresis. Ana Biochem 1995; 230: 123–129
   Google Scholar
• Liu C. L., Muddiman D. C., Tang K., Smith R. D. Improving the microdialysis procedure for electrospray ionisation mass spectrometry of biological samples. J Mass Spectrom 1997; 32: 425–431
   Google Scholar
• Jansson C., Boguszewski C., Rosberg S., Carlson L., Albertsson-Wikland K. Growth hormone (GH) assays: influence of standard preparations, GH isoforms, assay characteristics, and GH-binding protein. Clin. Chem. 1997; 43: 950–956
   PubMedGoogle Scholar
• Tang Q., Harrata K., Lee C. S. Comparison of protein separation in capillary zone electrophoresis and capillary isoelectric focusing interfacing with electrospray mass spectrometry. J. Mass Spectrom. 1996; 31: 1284–1290
   Google Scholar
• Jespersen S., Koedam J. A., Hoogerbrugge C. M., Tjaden U. R., van der Greef J., Van den Brande J. L. Characterisation of O-glycosylated precursors of insulin-like growth factor II by Matrix-assisted laser desorption/ionisation mass spectrometry. J. Mass Spectrom. 1996; 31: 893–900
   Google Scholar
• Liu C. L., Bowers L. D. Mass characterisation of the beta-subunit of human chorionic gonadotropin. J. Mass Spectrom. 1997; 32: 33–42
   Google Scholar
• Nieto O., Hernandez P., Hernandez L. Capillary Zone Electrophoresis of human recombinant erythropoietin using C8 coated columns without additives in the running buffer. Anal. Comm. 1996; 33: 425–427
   Google Scholar
• Bowers L. D. Analytical advances in detection of performance-enhancing compounds. Clinical Chem. 1997; 43: 1299–1304
   Google Scholar
• Bower L. D., Fregien K. HPLC/MS confirmation of peptide hormones in urine: evaluation of limit of detection. Recent advances in doping analysis(1), M. Donike, et al. Sport und Buch Strauss, Kln 1994; Vol. 3: 175–184
   Google Scholar
• Lam C. W., Lawson A. M., Hjelm N. M. Electrospray Mass Spectrometry of proteins in biomedicine. J Intern. Fed. Clinical Chem. 1997; 9: 72–75
   Google Scholar
• Liu C., Bowers L. D. Immunoaffinity trapping of urinary human chorionic gonadotropin and its high performance liquid chromatographic-mass spectrometric confirmation. J. Chromatogr. B 1996; 687: 213–220
   Google Scholar
• Linsley K. B., Chan S. Y., Chan S., Reinhold B. B., Lisi P. J., Reinhold V. N. Applications of electrospray mass spectrometry erythropoietin N-and O-linked glycans. Anal. Biochem. 1994; 219: 207–217
   Google Scholar